Literature DB >> 16179901

Low-molecular-weight heparin and survival in patients with malignant disease.

Ajay K Kakkar1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16179901     DOI： 10.1177/1073274805012003S05

Source DB:  PubMed          Journal:  Cancer Control        ISSN： 1073-2748            Impact factor:   3.302


× No keyword cloud information.
  6 in total

1.  D-dimer as a potential prognostic marker.

Authors:  Zsuzsanna Nagy; Orsolya Horváth; Julia Kádas; Dorottya Valtinyi; Larisza László; Bence Kopper; György Blaskó
Journal:  Pathol Oncol Res       Date:  2012-07       Impact factor: 3.201

Review 2.  The coagulome and the oncomir: impact of cancer-associated haemostatic dysregulation on the risk of metastasis.

Authors:  Kate Burbury; Michael P MacManus
Journal:  Clin Exp Metastasis       Date:  2018-02-28       Impact factor: 5.150

3.  The effect of LMWH (Nadroparin) on tumor progression.

Authors:  Zsuzsanna Nagy; Vera Turcsik; György Blaskó
Journal:  Pathol Oncol Res       Date:  2009-12       Impact factor: 3.201

4.  Idiopathic and recurrent thromboembolic phenomena in cancer patients.

Authors:  Miriam López-Gómez; César Gómez-Raposo; María Sereno Moyano; Enrique Casado-Sáenz; Jaime Feliú Batlle; Carolina Ortega Ruipérez; Manuel González Barón
Journal:  Clin Transl Oncol       Date:  2008-10       Impact factor: 3.405

Review 5.  Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review.

Authors:  Elie A Akl; Frederiek F van Doormaal; Maddalena Barba; Ganesh Kamath; Seo Young Kim; Saskia Kuipers; Saskia Middeldorp; Victor Yosuico; Heather O Dickinson; Holger J Schünemann
Journal:  J Exp Clin Cancer Res       Date:  2008-05-15

6.  High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension.

Authors:  Manabu Sakurai; Toyomi Satoh; Koji Matsumoto; Hiroo Michikami; Yuko Nakamura; Sari Nakao; Hiroyuki Ochi; Mamiko Onuki; Takeo Minaguchi; Hiroyuki Yoshikawa
Journal:  Int J Gynecol Cancer       Date:  2015-05       Impact factor: 3.437
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.